(Q34363448)

English

The impact of memantine in combination with acetylcholinesterase inhibitors on admission of patients with Alzheimer's disease to nursing homes: cost-effectiveness analysis in France

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

The impact of memantine in combination with acetylcholinesterase inhibitors on admission of patients with Alzheimer's disease to nursing homes: cost-effectiveness analysis in France (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Alzheimer's disease

0 references

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jacques Touchon

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Jean Lachaine

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Catherine Beauchemin

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Anna Granghaud

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Benoit Rive

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sébastien Bineau

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

9 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

The European Journal of Health Economics

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

791-800

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

9 August 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

A review of the effects of memantine on clinical progression in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201748

6 July 2018

Cost of dementia in the pre-enlargement countries of the European Union

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201748

6 July 2018

Predictors of adherence among Alzheimer's disease patients receiving oral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201748

6 July 2018

Memantine: a review of its use in moderate to severe Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201748

6 July 2018

Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201748

6 July 2018

Predictors of nursing home admission for persons with dementia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201748

6 July 2018

Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201748

6 July 2018

NICE cost-effectiveness appraisal of cholinesterase inhibitors: was the right question posed? Were the best tools used?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201748

6 July 2018

Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201748

6 July 2018

Added therapeutic value of memantine in the treatment of moderate to severe Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201748

6 July 2018

Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201748

6 July 2018

Cholinesterase inhibitors for Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201748

6 July 2018

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201748

6 July 2018

Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201748

6 July 2018

Patient and caregiver characteristics and nursing home placement in patients with dementia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201748

6 July 2018

The incidence of dementia: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201748

6 July 2018

The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project.

1 reference

https://api.crossref.org/works/10.1007%2FS10198-013-0523-Y

21 January 2018

Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease--a unified glutamatergic hypothesis on the mechanism of action

1 reference

https://api.crossref.org/works/10.1007%2FS10198-013-0523-Y

21 January 2018

Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine).

1 reference

https://api.crossref.org/works/10.1007%2FS10198-013-0523-Y

21 January 2018

Memantine in moderate-to-severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS10198-013-0523-Y

21 January 2018

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS10198-013-0523-Y

21 January 2018

Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS10198-013-0523-Y

21 January 2018

Assessment of health economics in Alzheimer's disease (AHEAD) based on need for full-time care.

1 reference

https://api.crossref.org/works/10.1007%2FS10198-013-0523-Y

21 January 2018

Assessment of health economics in Alzheimer's disease (AHEAD): galantamine treatment in Canada

1 reference

https://api.crossref.org/works/10.1007%2FS10198-013-0523-Y

21 January 2018

Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil.

1 reference

https://api.crossref.org/works/10.1007%2FS10198-013-0523-Y

21 January 2018

Economic evaluation of the impact of memantine on time to nursing home admission in the treatment of Alzheimer disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201748

27 October 2018

Caregivers' preferences for the treatment of patients with Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201748

27 October 2018

Mortality with dementia: results from a French prospective community-based cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/23928827

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health utilities in Alzheimer's disease: a cross-sectional study of patients and caregivers

1 reference

https://pubmed.ncbi.nlm.nih.gov/23928827

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France

1 reference

https://pubmed.ncbi.nlm.nih.gov/23928827

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychotropic drug consumption at admission and discharge of nursing home residents

1 reference

https://pubmed.ncbi.nlm.nih.gov/23928827

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10198-013-0523-Y

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34363448&oldid=2196551318"